The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.

CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.

The research team at UQ has secured a grant of $344,000 from the National Foundation for Medical Research and Innovation.

There is no excerpt because this is a protected post.

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...

The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.

University of Birmingham researchers have identified CD70 as a key target to reduce the risk of GVHD in blood cancer patients ...

The government said that men are less likely than women to seek medical help, particularly for mental health issues.

Meningitis C cases are down 99% since the NHS routine vaccination programme was introduced by UKHSA and NHS England in 1999.

Automated Industrial Robotics have delivered a bespoke Just in Time PACE system to CPI’s new Medicines Manufacturing ...

Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its ADC ...

Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 for post-operative inflammation and pain after ...